GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Marketable Securities

Ipca Laboratories (BOM:524494) Marketable Securities : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ipca Laboratories's Marketable Securities for the quarter that ended in Dec. 2023 was ₹0 Mil.

Ipca Laboratories's annual Marketable Securities increased from Mar. 2021 (₹5,917 Mil) to Mar. 2022 (₹10,835 Mil) but then declined from Mar. 2022 (₹10,835 Mil) to Mar. 2023 (₹9,173 Mil).


Ipca Laboratories Marketable Securities Historical Data

The historical data trend for Ipca Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Marketable Securities Chart

Ipca Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 903.80 3,594.00 5,916.70 10,834.90 9,173.10

Ipca Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 9,173.10 - 6,033.40 -

Ipca Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Ipca Laboratories  (BOM:524494) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Ipca Laboratories Marketable Securities Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories (BOM:524494) Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines